mynth
06/2014MajorityLBO

PAI Partners takes majority stake in Domusvi

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV €500M–1.5bn

Context

PAI Partners has entered into exclusive negotiations to take control of DomusVi, the third largest French player in the private nursing home sector. Upon completion of the transaction, PAI is expected to hold 70% of the capital alongside an associated fund. The remaining shareholding structure will include DV Holding (controlled by founder Yves Journel) at 25% and the group's management at 5%. This operation facilitates the full exit of the other founding shareholder, Jean,François Gobertier, thereby resolving a long,standing governance conflict between the two founders. The strategic rationale for the deal centers on the consolidation of a market where private actors are gaining share as the state's capacity to maintain market share diminishes. PAI Partners plans to optimize the existing facilities and reduce costs while funding an aggressive acquisition strategy. Several hundred million euros are planned over the next five years for targeted acquisitions, specifically aiming to strengthen the group's presence in Germany and Spain and to continue its development in China. This step is intended to simplify the company’s governance and transform it into an international champion in the management of elderly dependency.

The acquisition of Domusvi is part of the growth strategy of PAI Partners, which already has several external growth operations under its belt, notably Euro Media Group in 2014.

Domusvi, which reported an EBITDA margin of [members only] in 2013, is valued in this transaction at an EV/EBITDA multiple of 10x–18x.

-> Deep-dive in Healthcare & Pharma market trends

Target

DomusVi stands as a leading international provider of high-quality elderly care and specialized services. The group operates an extensive cross-border network across Europe and Latin America, encompassing medicalized nursing homes, mental health facilities, and home care agencies. The entity actively executes a targeted buy-and-build strategy aimed at securing and strengthening its premier position within its domestic market. DomusVi’s value proposition is built upon a multi-disciplinary approach to dependency and senior care, seamlessly integrating medicalized residential care, specialized disability centers, and home assistance solutions to deliver a comprehensive support ecosystem for seniors and their families.

Ent. Value

€500M–1.5bn

Equity Value

[members only]

Multiples

EV / Revenue

below 1.5x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2013
€450–900M
€50–100M
[members only]
2012
€450–900M
€50–100M
[members only]

Other operations with Domusvi

Other operations with Domusvi
DateAcquirerTargetCountrySector
04/2021ICG / MANAGEMENT & PRIVATE INVESTORSDOMUSVIFRANCENursing Homes
03/2019DOMUSVIRESIDALYAFRANCENursing Homes
06/2017ICG / MANAGEMENT & PRIVATE INVESTORSDOMUSVIFRANCENursing Homes
10/2016DOMUSVISARQUAVITAESPAINNursing Homes

Other operations with PAI Partners

Other operations with PAI Partners
DateAcquirerTargetCountrySector
02/2016ADB SAFEGATE / PAI PARTNERSSAFEGATE INTERNATIONALSWEDENAerospace, Naval & Defense
12/2015PAI PARTNERSGROUPE B&B HOTELSFRANCEHotels & Accommodation
06/2014PAI PARTNERSVPS HOLDINGSUNITED KINGDOMSecurity & Guarding
06/2014PAI PARTNERSLABEYRIE FINE FOODSFRANCEFood Products
04/2014PAI PARTNERSEURO MEDIA GROUPFRANCEAudiovisual Production
04/2014PAI PARTNERS / THE CARLYLE GROUPINNOVISTA (EX CST)FRANCESensors & Optics
11/2013PAI PARTNERSADB SAFEGATEBELGIUMAerospace, Naval & Defense
03/2013PAI PARTNERSIPH GROUPFRANCEIndustrial & Technical Distribution
10/2012PAI PARTNERSMARCOLINITALYLuxury Supply Chain
06/2010PAI PARTNERSCERBA HEALTHCAREFRANCELabs (Biology)

Similar deals in Health Providers

Similar deals in Health Providers
DateAcquirerTargetCountrySector
01/2015CERBA HEALTHCARENOVESCIAFRANCELabs (Biology)
10/2014WATERLANDMEDIAN KLINIKENGERMANYClinics / Hospitals
09/2014EURAZEOCOLISÉEFRANCENursing Homes
03/2014EQT PARTNERSI-MED RADIOLOGY NETWORKAUSTRALIARadiology
07/2012MANAGEMENT & PRIVATE INVESTORSLVL MEDICAL GERMANYGERMANYOutpatient Care
06/2012AIR LIQUIDEORKYN (EX LVL MEDICAL)FRANCEOutpatient Care
12/2010SAGA GROUPNESTOR HEALTHCARE GROUPUNITED KINGDOMOutpatient Care
06/2010PAI PARTNERSCERBA HEALTHCAREFRANCELabs (Biology)
05/2010HG CAPITALFRÖSUNDASWEDENHealthcare Facilities
03/2010BRIDGEPOINTCARE UKUNITED KINGDOMNursing Homes

REFERENCES

Valuation range: EV €500M–1.5bn

Revenue range: €450–900M

EBITDA range: €50–100M

EV/Revenue range: below 1.5x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Domusvi by PAI Partners are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Domusvi, a French company specialised in Healthcare Facilities, by PAI Partners in 2014, structured as a leveraged buyout (LBO). Ownership has since evolved, leading to a subsequent transaction with ICG / Management & Private Investors in June 2017 (see the dedicated deal page for details).

How was the acquisition of Domusvi by PAI Partners valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the €500M–1.5bn band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the below 1.5x range. Exact figures are available to members.

What were Domusvi’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Domusvi generated annual revenue estimated in the €450–900M range and EBITDA in the €50–100M bracket (FY 2013). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction intelligence is supported by independent reporting from specialized financial publications, alongside a private document shared by the community and verified by the mynth team to ensure the accuracy of the shared information.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.